11 insiders reported 73 Form 4 transactions for Aurinia Pharmaceuticals Inc. (AUPH) over the past 18 months (most recent 2026-06-02). Recent activity: TANG CAPITAL MANAGEMENT LLC (10% Owner) Buy 2,299 shares, TANG KEVIN (Chief Executive Officer) Buy 262,682 shares, TANG CAPITAL MANAGEMENT LLC (10% Owner) Buy 262,682 shares, TANG CAPITAL MANAGEMENT LLC (10% Owner) Buy 343,521 shares, TANG KEVIN (Chief Executive Officer) Buy 343,521 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 2,299 | $35,290 |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 262,682 | $4.0M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 262,682 | $4.0M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 343,521 | $5.2M |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 343,521 | $5.2M |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 99 | $1,519 |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 99 | $1,519 |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 206,005 | $3.1M |
| 2026-06-02 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 206,005 | $3.1M |
| 2026-06-02 | TANG KEVIN | Chief Executive Officer | Buy | 2,299 | $35,290 |
| 2026-05-20 | Cole Ryan | Chief Operating Officer | Buy | 116,144 | $0 |
| 2026-05-20 | Robertson Stephen P. | Chief Legal Officer | Buy | 115,541 | $0 |
| 2026-05-20 | Hearne Michael S | Chief Financial Officer | Buy | 116,144 | $0 |
| 2026-03-10 | Keenan Greg | SVP, Chief Medical Officer | Sell | 8,069 | $115,548 |
| 2026-03-03 | TANG KEVIN | Director | Buy | 300,000 | $4.2M |
| 2026-03-03 | Miller Joseph M | Chief Financial Officer | Sell | 37,511 | $533,031 |
| 2026-03-03 | Donley Matthew Maxwell | Chief Operating Officer | Buy | 58,160 | $0 |
| 2026-03-03 | Donley Matthew Maxwell | Chief Operating Officer | Sell | 40,761 | $579,214 |
| 2026-03-03 | Greenleaf Peter | Chief Executive Officer | Buy | 196,403 | $0 |
| 2026-03-03 | Greenleaf Peter | Chief Executive Officer | Sell | 100,890 | $1.4M |
| 2026-03-03 | Robertson Stephen P. | EVP, General Counsel | Buy | 59,090 | $0 |
| 2026-03-03 | Robertson Stephen P. | EVP, General Counsel | Sell | 36,525 | $519,020 |
| 2026-03-03 | Keenan Greg | SVP, Chief Medical Officer | Buy | 40,586 | $0 |
| 2026-03-03 | Miller Joseph M | Chief Financial Officer | Buy | 57,229 | $0 |
| 2026-03-03 | TANG KEVIN | Director | Buy | 214,839 | $3.0M |
Source: SEC Form 4 filings · as of 2026-06-02